What Happened?
San Francisco, CA-based Audentes Therapeutics Resigned John Gray as Senior Vice President and Chief Technology Officer
About the Company
Audentes is a biotechnology company committed to the development and commercialization of innovative new medicines for people with serious, rare muscle diseases. We are a passionate, energetic team driven by the goals of improving the lives of patients and building a successful business. We take pride in strong, global relationships with the patient, research, and medical communities.
About the Person
John Gray is Senior Vice President and Chief Technology Officer at Audentes Therapeutics. Previously, John held various senior IT leadership roles in the industry.
Info Source
News
Short Profile